Koers Bud Genius, Inc. Other OTC
Aandelen
RIGH
US76657X1110
Biotechnologie & Medisch Onderzoek
Omzet 2009 | - | Omzet 2010 | 0,04 0,04 | Marktkapitalisatie | 11,25K 10,35K |
---|---|---|---|---|---|
Nettowinst (verlies) 2009 | - 0 | Nettowinst (verlies) 2010 | - 0 | EV/omzet 2009 | - |
Nettoschuld 2009 | 489K 450K | Nettoschuld 2010 | 396K 364K | EV/omzet 2010 | 9.639.795 x |
K/w-verhouding 2009 |
-23,5
x | K/w-verhouding 2010 |
-
| Werknemers | - |
Dividendrendement 2009 * |
-
| Dividendrendement 2010 |
-
| Vrij verhandelbaar | 690,57% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+41,79% | 54,04 mld. | |
-0,56% | 41,92 mld. | |
+47,92% | 41,96 mld. | |
-7,20% | 28,35 mld. | |
+12,59% | 26,35 mld. | |
-21,51% | 19 mld. | |
+6,92% | 13 mld. | |
+24,91% | 12,19 mld. | |
+29,60% | 12,28 mld. |